메뉴 건너뛰기




Volumn 7, Issue 6, 2012, Pages

Monoclonal antibodies to the V2 domain of MN-rgp120: Fine mapping of epitopes and inhibition of α4β7 binding

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; INTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1017; MONOCLONAL ANTIBODY 1019; MONOCLONAL ANTIBODY 1022; MONOCLONAL ANTIBODY 1025; MONOCLONAL ANTIBODY 1026; MONOCLONAL ANTIBODY 1027; MONOCLONAL ANTIBODY 1028; MONOCLONAL ANTIBODY 1029; MONOCLONAL ANTIBODY 1088; MONOCLONAL ANTIBODY 6E10; MONOCLONAL ANTIBODY B12; MONOCLONAL ANTIBODY FIB504 64; MONOCLONAL ANTIBODY PG9; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

EID: 84862173040     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039045     Document Type: Article
Times cited : (39)

References (60)
  • 1
    • 0026647845 scopus 로고
    • Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1
    • Berman PW, Matthews TJ, Riddle L, Champe M, Hobbs MR, et al. (1992) Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. J Virol 66: 4464-9.
    • (1992) J Virol , vol.66 , pp. 4464-4469
    • Berman, P.W.1    Matthews, T.J.2    Riddle, L.3    Champe, M.4    Hobbs, M.R.5
  • 2
    • 0028024901 scopus 로고
    • Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network
    • Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, et al. (1994) Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. Jama 272: 475-80.
    • (1994) Jama , vol.272 , pp. 475-480
    • Belshe, R.B.1    Graham, B.S.2    Keefer, M.C.3    Gorse, G.J.4    Wright, P.5
  • 3
    • 19144370387 scopus 로고    scopus 로고
    • Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1
    • Berman PW, Murthy KK, Wrin T, Vennari JC, Cobb EK, et al. (1996) Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. J Infect Dis 173: 52-9.
    • (1996) J Infect Dis , vol.173 , pp. 52-59
    • Berman, P.W.1    Murthy, K.K.2    Wrin, T.3    Vennari, J.C.4    Cobb, E.K.5
  • 5
    • 0031764239 scopus 로고    scopus 로고
    • Development of bivalent rgp120 vaccines to prevent HIV type 1 infection
    • Berman PW, (1998) Development of bivalent rgp120 vaccines to prevent HIV type 1 infection. AIDS Res Hum Retroviruses 14: S277-89.
    • (1998) AIDS Res Hum Retroviruses , vol.14
    • Berman, P.W.1
  • 6
    • 0033527905 scopus 로고    scopus 로고
    • Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand
    • Berman PW, Huang W, Riddle L, Gray AM, Wrin T, et al. (1999) Development of bivalent (B/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand. Virology 265: 1-9.
    • (1999) Virology , vol.265 , pp. 1-9
    • Berman, P.W.1    Huang, W.2    Riddle, L.3    Gray, A.M.4    Wrin, T.5
  • 8
    • 13944254982 scopus 로고    scopus 로고
    • Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
    • Flynn NM, Forthal DN, Harro CD, Judson FN, Mayer KH, et al. (2005) Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 191: 654-65.
    • (2005) J Infect Dis , vol.191 , pp. 654-665
    • Flynn, N.M.1    Forthal, D.N.2    Harro, C.D.3    Judson, F.N.4    Mayer, K.H.5
  • 9
    • 33845433434 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
    • Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, et al. (2006) Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 194: 1661-71.
    • (2006) J Infect Dis , vol.194 , pp. 1661-1671
    • Pitisuttithum, P.1    Gilbert, P.2    Gurwith, M.3    Heyward, W.4    Martin, M.5
  • 10
    • 19944423187 scopus 로고    scopus 로고
    • Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays
    • Montefiori D, (2004) Evaluating neutralizing antibodies against HIV, SIV and SHIV in luciferase reporter gene assays. Current Protocols in Immunology 12.11.1-12.11.15.
    • (2004) Current Protocols in Immunology , pp. 1-15
    • Montefiori, D.1
  • 12
    • 84863932778 scopus 로고    scopus 로고
    • Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and VAX003 HIV-1 Vaccine Efficacy Trials
    • Montefiori DC, Karnasuta C, Huang Y, Ahmed H, Gilbert P, et al. (2012) Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and VAX003 HIV-1 Vaccine Efficacy Trials. J. Infect Dis In press.
    • (2012) J. Infect Dis In Press
    • Montefiori, D.C.1    Karnasuta, C.2    Huang, Y.3    Ahmed, H.4    Gilbert, P.5
  • 13
    • 34248168722 scopus 로고    scopus 로고
    • Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate
    • Forthal DN, Gilbert PB, Landucci G, Phan T, (2007) Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate. J Immunol 178: 6596-603.
    • (2007) J Immunol , vol.178 , pp. 6596-6603
    • Forthal, D.N.1    Gilbert, P.B.2    Landucci, G.3    Phan, T.4
  • 14
    • 70350306659 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus
    • Lai SK, Hida K, Shukair S, Wang YY, Figueiredo A, et al. (2009) Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 83: 11196-200.
    • (2009) J Virol , vol.83 , pp. 11196-11200
    • Lai, S.K.1    Hida, K.2    Shukair, S.3    Wang, Y.Y.4    Figueiredo, A.5
  • 15
    • 73949112038 scopus 로고    scopus 로고
    • The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1
    • Cicala C, Martinelli E, McNally JP, Goode DJ, Gopaul R, et al. (2009) The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A 106: 20877-82.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 20877-20882
    • Cicala, C.1    Martinelli, E.2    McNally, J.P.3    Goode, D.J.4    Gopaul, R.5
  • 16
    • 84873444719 scopus 로고    scopus 로고
    • Clues emerge to explain first successful HIV vaccine trial
    • DOI: 10.1038/news.2011.541
    • Callaway E, (2011) Clues emerge to explain first successful HIV vaccine trial. NatureNews DOI: 10.1038/news.2011.541.
    • (2011) NatureNews
    • Callaway, E.1
  • 17
    • 0031666180 scopus 로고    scopus 로고
    • An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades
    • Stamatatos L, Cheng-Mayer C, (1998) An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades. J Virol 72: 7840-5.
    • (1998) J Virol , vol.72 , pp. 7840-7845
    • Stamatatos, L.1    Cheng-Mayer, C.2
  • 18
    • 2342644898 scopus 로고    scopus 로고
    • The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection
    • Pinter A, Honnen WJ, He Y, Gorny MK, Zolla-Pazner S, et al. (2004) The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J Virol 78: 5205-15.
    • (2004) J Virol , vol.78 , pp. 5205-5215
    • Pinter, A.1    Honnen, W.J.2    He, Y.3    Gorny, M.K.4    Zolla-Pazner, S.5
  • 19
    • 21644446614 scopus 로고    scopus 로고
    • The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner
    • Saunders CJ, McCaffrey RA, Zharkikh I, Kraft Z, Malenbaum SE, et al. (2005) The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J Virol 79: 9069-80.
    • (2005) J Virol , vol.79 , pp. 9069-9080
    • Saunders, C.J.1    McCaffrey, R.A.2    Zharkikh, I.3    Kraft, Z.4    Malenbaum, S.E.5
  • 20
    • 77958115264 scopus 로고    scopus 로고
    • A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals
    • Walker LM, Simek MD, Priddy F, Gach JS, Wagner D, et al. (2010) A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog 6: e1001028.
    • (2010) PLoS Pathog , vol.6
    • Walker, L.M.1    Simek, M.D.2    Priddy, F.3    Gach, J.S.4    Wagner, D.5
  • 21
    • 79952579682 scopus 로고    scopus 로고
    • Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop
    • Moore PL, Gray ES, Sheward D, Madiga M, Ranchobe N, et al. (2011) Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop. J Virol 85: 3128-41.
    • (2011) J Virol , vol.85 , pp. 3128-3141
    • Moore, P.L.1    Gray, E.S.2    Sheward, D.3    Madiga, M.4    Ranchobe, N.5
  • 22
    • 70349887757 scopus 로고    scopus 로고
    • Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
    • Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, et al. (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326: 285-9.
    • (2009) Science , vol.326 , pp. 285-289
    • Walker, L.M.1    Phogat, S.K.2    Chan-Hui, P.Y.3    Wagner, D.4    Phung, P.5
  • 23
    • 39449098115 scopus 로고    scopus 로고
    • HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells
    • Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, et al. (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9: 301-9.
    • (2008) Nat Immunol , vol.9 , pp. 301-309
    • Arthos, J.1    Cicala, C.2    Martinelli, E.3    Macleod, K.4    van Ryk, D.5
  • 24
    • 0024523655 scopus 로고
    • Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes
    • Gowda SD, Stein BS, Mohagheghpour N, Benike CJ, Engleman EG, (1989) Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol 142: 773-80.
    • (1989) J Immunol , vol.142 , pp. 773-780
    • Gowda, S.D.1    Stein, B.S.2    Mohagheghpour, N.3    Benike, C.J.4    Engleman, E.G.5
  • 25
    • 0025238945 scopus 로고
    • HIV-1 replication is controlled at the level of T cell activation and proviral integration
    • Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA, (1990) HIV-1 replication is controlled at the level of T cell activation and proviral integration. Embo J 9: 1551-60.
    • (1990) Embo J , vol.9 , pp. 1551-1560
    • Stevenson, M.1    Stanwick, T.L.2    Dempsey, M.P.3    Lamonica, C.A.4
  • 26
    • 0025342694 scopus 로고
    • HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure
    • Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, et al. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-22.
    • (1990) Cell , vol.61 , pp. 213-222
    • Zack, J.A.1    Arrigo, S.J.2    Weitsman, S.R.3    Go, A.S.4    Haislip, A.5
  • 27
    • 0027050366 scopus 로고
    • Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates
    • Nakamura GR, Byrn R, Rosenthal K, Porter JP, Hobbs MR, et al. (1992) Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates. AIDS Res Hum Retroviruses 8: 1875-85.
    • (1992) AIDS Res Hum Retroviruses , vol.8 , pp. 1875-1885
    • Nakamura, G.R.1    Byrn, R.2    Rosenthal, K.3    Porter, J.P.4    Hobbs, M.R.5
  • 28
    • 0027170414 scopus 로고
    • Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1
    • Nakamura GR, Byrn R, Wilkes DM, Fox JA, Hobbs MR, et al. (1993) Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1. J Virol 67: 6179-91.
    • (1993) J Virol , vol.67 , pp. 6179-6191
    • Nakamura, G.R.1    Byrn, R.2    Wilkes, D.M.3    Fox, J.A.4    Hobbs, M.R.5
  • 29
    • 44649102135 scopus 로고    scopus 로고
    • Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
    • Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552-7.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 7552-7557
    • Keele, B.F.1    Giorgi, E.E.2    Salazar-Gonzalez, J.F.3    Decker, J.M.4    Pham, K.T.5
  • 31
    • 0028321412 scopus 로고
    • Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes
    • Erle DJ, Briskin MJ, Butcher EC, Garcia-Pardo A, Lazarovits AI, et al. (1994) Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J Immunol 153: 517-28.
    • (1994) J Immunol , vol.153 , pp. 517-528
    • Erle, D.J.1    Briskin, M.J.2    Butcher, E.C.3    Garcia-Pardo, A.4    Lazarovits, A.I.5
  • 32
    • 16244419386 scopus 로고    scopus 로고
    • Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles
    • Gorny MK, Stamatatos L, Volsky B, Revesz K, Williams C, et al. (2005) Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J Virol 79: 5232-7.
    • (2005) J Virol , vol.79 , pp. 5232-5237
    • Gorny, M.K.1    Stamatatos, L.2    Volsky, B.3    Revesz, K.4    Williams, C.5
  • 33
    • 77954100808 scopus 로고    scopus 로고
    • Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
    • Zolla-Pazner S, Cardozo T, (2010) Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. Nat Rev Immunol 10: 527-35.
    • (2010) Nat Rev Immunol , vol.10 , pp. 527-535
    • Zolla-Pazner, S.1    Cardozo, T.2
  • 34
    • 83455254775 scopus 로고    scopus 로고
    • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
    • McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, et al. (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480: 336-43.
    • (2011) Nature , vol.480 , pp. 336-343
    • McLellan, J.S.1    Pancera, M.2    Carrico, C.3    Gorman, J.4    Julien, J.P.5
  • 35
    • 80052938385 scopus 로고    scopus 로고
    • Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
    • Bonsignori M, Hwang KK, Chen X, Tsao CY, Morris L, et al. (2011) Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors. J Virol 85: 9998-10009.
    • (2011) J Virol , vol.85 , pp. 9998-10009
    • Bonsignori, M.1    Hwang, K.K.2    Chen, X.3    Tsao, C.Y.4    Morris, L.5
  • 36
    • 84872500976 scopus 로고    scopus 로고
    • Analysis of the V2 Antibody Response Induced in Vaccinees Participating in the ALVAC/AIDSVAX HIV-1 Clinical Vaccine Trial
    • Zolla-Pazner S, DeCamp A, Cardozo T, Karasavvas N, Gottardo R, et al. (2012) Analysis of the V2 Antibody Response Induced in Vaccinees Participating in the ALVAC/AIDSVAX HIV-1 Clinical Vaccine Trial. J Virol In press.
    • (2012) J Virol In Press
    • Zolla-Pazner, S.1    DeCamp, A.2    Cardozo, T.3    Karasavvas, N.4    Gottardo, R.5
  • 37
    • 77957940271 scopus 로고    scopus 로고
    • Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus
    • O'Rourke SM, Schweighardt B, Phung P, Fonseca DP, Terry K, et al. (2010) Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virus. J Virol 84: 11200-9.
    • (2010) J Virol , vol.84 , pp. 11200-11209
    • O'Rourke, S.M.1    Schweighardt, B.2    Phung, P.3    Fonseca, D.P.4    Terry, K.5
  • 38
    • 0032543307 scopus 로고    scopus 로고
    • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
    • Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, et al. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-59.
    • (1998) Nature , vol.393 , pp. 648-659
    • Kwong, P.D.1    Wyatt, R.2    Robinson, J.3    Sweet, R.W.4    Sodroski, J.5
  • 40
    • 0026595148 scopus 로고
    • Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120
    • Fung MS, Sun CR, Gordon WL, Liou RS, Chang TW, et al. (1992) Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J Virol 66: 848-56.
    • (1992) J Virol , vol.66 , pp. 848-856
    • Fung, M.S.1    Sun, C.R.2    Gordon, W.L.3    Liou, R.S.4    Chang, T.W.5
  • 41
    • 0027199489 scopus 로고
    • Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120
    • McKeating JA, Shotton C, Cordell J, Graham S, Balfe P, et al. (1993) Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120. J Virol 67: 4932-44.
    • (1993) J Virol , vol.67 , pp. 4932-4944
    • McKeating, J.A.1    Shotton, C.2    Cordell, J.3    Graham, S.4    Balfe, P.5
  • 42
    • 0027278133 scopus 로고
    • A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1
    • Moore JP, (1993) A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1. J Virol 67: 3656-9.
    • (1993) J Virol , vol.67 , pp. 3656-3659
    • Moore, J.P.1
  • 43
    • 0028027741 scopus 로고
    • Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1
    • Gorny MK, Moore JP, Conley AJ, Karwowska S, Sodroski J, et al. (1994) Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. J Virol 68: 8312-20.
    • (1994) J Virol , vol.68 , pp. 8312-8320
    • Gorny, M.K.1    Moore, J.P.2    Conley, A.J.3    Karwowska, S.4    Sodroski, J.5
  • 44
    • 0028924753 scopus 로고
    • Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein
    • Shotton C, Arnold C, Sattentau Q, Sodroski J, McKeating JA, (1995) Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol 69: 222-30.
    • (1995) J Virol , vol.69 , pp. 222-230
    • Shotton, C.1    Arnold, C.2    Sattentau, Q.3    Sodroski, J.4    McKeating, J.A.5
  • 45
    • 0028965263 scopus 로고
    • Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain
    • Wu Z, Kayman SC, Honnen W, Revesz K, Chen H, et al. (1995) Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. J Virol 69: 2271-8.
    • (1995) J Virol , vol.69 , pp. 2271-2278
    • Wu, Z.1    Kayman, S.C.2    Honnen, W.3    Revesz, K.4    Chen, H.5
  • 46
    • 0029891454 scopus 로고    scopus 로고
    • Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site
    • Vijh-Warrier S, Pinter A, Honnen WJ, Tilley SA, (1996) Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site. J Virol 70: 4466-73.
    • (1996) J Virol , vol.70 , pp. 4466-4473
    • Vijh-Warrier, S.1    Pinter, A.2    Honnen, W.J.3    Tilley, S.A.4
  • 47
    • 33846556067 scopus 로고    scopus 로고
    • Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence
    • Honnen WJ, Krachmarov C, Kayman SC, Gorny MK, Zolla-Pazner S, et al. (2007) Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence. J Virol 81: 1424-32.
    • (2007) J Virol , vol.81 , pp. 1424-1432
    • Honnen, W.J.1    Krachmarov, C.2    Kayman, S.C.3    Gorny, M.K.4    Zolla-Pazner, S.5
  • 48
    • 33646146379 scopus 로고    scopus 로고
    • GP120: target for neutralizing HIV-1 antibodies
    • Pantophlet R, Burton DR, (2006) GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24: 739-69.
    • (2006) Annu Rev Immunol , vol.24 , pp. 739-769
    • Pantophlet, R.1    Burton, D.R.2
  • 50
    • 13944250922 scopus 로고    scopus 로고
    • Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
    • Gilbert PB, Peterson ML, Follmann D, Hudgens MG, Francis DP, et al. (2005) Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis 191: 666-77.
    • (2005) J Infect Dis , vol.191 , pp. 666-677
    • Gilbert, P.B.1    Peterson, M.L.2    Follmann, D.3    Hudgens, M.G.4    Francis, D.P.5
  • 51
    • 18744394633 scopus 로고    scopus 로고
    • The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates
    • Pinter A, Honnen WJ, D'Agostino P, Gorny MK, Zolla-Pazner S, et al. (2005) The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates. J Virol 79: 6909-17.
    • (2005) J Virol , vol.79 , pp. 6909-6917
    • Pinter, A.1    Honnen, W.J.2    D'Agostino, P.3    Gorny, M.K.4    Zolla-Pazner, S.5
  • 52
    • 0023885197 scopus 로고
    • Envelope sequences of two new United States HIV-1 isolates
    • Gurgo C, Guo HG, Franchini G, Aldovini A, Collalti E, et al. (1988) Envelope sequences of two new United States HIV-1 isolates. Virology 164: 531-6.
    • (1988) Virology , vol.164 , pp. 531-536
    • Gurgo, C.1    Guo, H.G.2    Franchini, G.3    Aldovini, A.4    Collalti, E.5
  • 53
    • 0021915799 scopus 로고
    • Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus
    • Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, et al. (1985) Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 313: 450-8.
    • (1985) Nature , vol.313 , pp. 450-458
    • Muesing, M.A.1    Smith, D.H.2    Cabradilla, C.D.3    Benton, C.V.4    Lasky, L.A.5
  • 54
    • 0025292252 scopus 로고
    • Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
    • Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, et al. (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265: 10373-82.
    • (1990) J Biol Chem , vol.265 , pp. 10373-10382
    • Leonard, C.K.1    Spellman, M.W.2    Riddle, L.3    Harris, R.J.4    Thomas, J.N.5
  • 55
    • 0016587194 scopus 로고
    • Recent progress in the peroxidase-labeled antibody method
    • Nakane PK, (1975) Recent progress in the peroxidase-labeled antibody method. Ann N Y Acad Sci 254: 203-11.
    • (1975) Ann N Y Acad Sci , vol.254 , pp. 203-211
    • Nakane, P.K.1
  • 56
    • 0031201061 scopus 로고    scopus 로고
    • Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1
    • Tidswell M, Pachynski R, Wu SW, Qiu SQ, Dunham E, et al. (1997) Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1. J Immunol 159: 1497-505.
    • (1997) J Immunol , vol.159 , pp. 1497-1505
    • Tidswell, M.1    Pachynski, R.2    Wu, S.W.3    Qiu, S.Q.4    Dunham, E.5
  • 57
    • 2642699794 scopus 로고
    • Rapid and efficient site-specific mutagenesis without phenotypic selection
    • Kunkel TA, (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A 82: 488-92.
    • (1985) Proc Natl Acad Sci U S A , vol.82 , pp. 488-492
    • Kunkel, T.A.1
  • 58
    • 0015847039 scopus 로고
    • A new technique for the assay of infectivity of human adenovirus 5 DNA
    • Graham FL, van der Eb AJ, (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-67.
    • (1973) Virology , vol.52 , pp. 456-467
    • Graham, F.L.1    van der Eb, A.J.2
  • 59
    • 0030877108 scopus 로고    scopus 로고
    • Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers
    • Berman PW, Gray AM, Wrin T, Vennari JC, Eastman DJ, et al. (1997) Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers. J Infect Dis 176: 384-97.
    • (1997) J Infect Dis , vol.176 , pp. 384-397
    • Berman, P.W.1    Gray, A.M.2    Wrin, T.3    Vennari, J.C.4    Eastman, D.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.